GELITA also plays a major role in the production of life-saving vaccines – for example those against the H1N1 virus that is responsible for the infamous swine flu of recent years. With GELITA^® VacciPro, we provide the pharmaceutical industry with a collagen peptide that has been optimized for the stabilization of vaccines and has been used by leading manufacturers in the development of the H1N1 vaccines. GELITA^® VacciPro is also ideal for use with injected vaccines as it has a very low allergenic potential, a high degree of bioavailability and an affinity to cell tissue. Thanks to its stabilizing properties, the collagen peptide has been declared the "gold standard" by a number of leading vaccine manufacturers.